RT Journal Article
SR Electronic
A1 Vinall, Maria
T1 DEFINE: CETP Inhibition with Anacetrapib Significantly Raises HDL Cholesterol and Further Lowers LDL
JF MD Conference Express
YR 2010
FD SAGE Publications
VO 10
IS 10
SP 13
OP 14
DO 10.1177/155989771010005
UL http://mdc.sagepub.com/content/10/10/13.abstract
AB This article discusses results from the Determining the Efficacy and Tolerability of CETP Inhibition with Anacetrapib [DEFINE; NCT00685776] trial, which showed that anacetrapib safely and substantially lowered LDL-C and raised HDL-C levels in patients with coronary heart disease.